Clinical Trial Update: Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetics study evaluating rifabutin when combined with antiretroviral therapy in TB/HIV co-infected patients in South Africa has been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• RIFABUTIN (Rifabutin)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections, Tuberculosis | Phase 2 | Status: COMPLETED